{"nct_id":"NCT03323398","title":"Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies","status":"TERMINATED","status_verified_date":"2024-06","start_date":"2017-08-15","start_date_type":"ACTUAL","primary_completion_date":"2021-08-18","primary_completion_date_type":"ACTUAL","completion_date":"2021-08-18","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MRNA"]}